ArticleFrontiers in immunology2022

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma.

Kai Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.